What's hot at EuroPCR 2024?

Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.

What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials?

Trials covered included:
00:46 - CAREER: Diagnostic performance of fully automatic computational FFR
02:03 - Angiography-based Radial Wall Strain in Predicting Non-Culprit Vessel Failure
04:05 - DOCTORS-LM: Does OCT Optimise Results of Stenting on the Left Main Stem
07:41 - TCW: Percutaneus versus surgical treatment for patients with aortic stenosis and coronary disease
09:35 - SOLVE-TAVI: mpact of valve type and anaesthesia strategy for TAVI 
12:27 - NOTION-2: First TAVI vs SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis
14:41 - LANDMARK: Early outcomes of a randomised non-inferiority trial comparing TAVI devices
16:36 - AltaValve: Early feasibility study
17:53 - LuxValvePlus: Transcatheter tricuspid valve implantation using the LuxValvePlus system: Compassionate use outcomes
19:12 - CALIPSO: OCT vs angiography for guidance of calcified lesions PCI
21:44 - ROTA-ISR: Debulking with rotational atherectomy versus balloon angioplasty in patients with in-stent restenosis
23:57 - ROLLERCOASTR: Balloon angioplasty versus shockwave intravascular lithotripsy
25:20 - Balloon Angioplasty Vs Shockwave Intravascular Lithotripsy
25:29 - OCT Vs IVUS: Primary outcome of randomised controlled trial of the safety and effectiveness for OCT or IVUS-guide